Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.52 USD | +2.45% | -6.82% | -38.91% |
May. 13 | Ajax Therapeutics, Inc. announced that it has received $95 million in funding from a group of investors | CI |
May. 07 | Ansys Partners With Schrodinger to Accelerate Materials Development | MT |
Business Summary
Number of employees: 867
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Software
73.4
%
| 136 | 74.9 % | 159 | 73.4 % | +17.37% |
Drug Discovery
26.6
%
| 45 | 25.1 % | 58 | 26.6 % | +26.81% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
74.8
%
| 124 | 68.3 % | 162 | 74.8 % | +31.08% |
EMEA
13.4
%
| - | - | 29 | 13.4 % | - |
APAC
11.3
%
| - | - | 25 | 11.3 % | - |
Rest of World
0.5
%
| 14 | 7.7 % | 1 | 0.5 % | -92.79% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Taffy
FOU | Founder | - | 20-12-31 |
Ramy Farid
CEO | Chief Executive Officer | 59 | 01-12-31 |
Geoffrey Porges
DFI | Director of Finance/CFO | 63 | 22-08-17 |
Margaret Dugan
CTO | Chief Tech/Sci/R&D Officer | 67 | 22-12-31 |
Patrick Lorton
CTO | Chief Tech/Sci/R&D Officer | 40 | 06-08-31 |
Shane Brauner
CTO | Chief Tech/Sci/R&D Officer | 47 | 09-01-31 |
Jaren Madden
IRC | Investor Relations Contact | - | 20-10-31 |
Jean Lachowicz
PRN | Corporate Officer/Principal | - | 22-12-31 |
Jenny Herman
AUD | Comptroller/Controller/Auditor | - | - |
Karen Akinsanya
PRN | Corporate Officer/Principal | 56 | 18-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arun Oberoi
BRD | Director/Board Member | 70 | 22-05-16 |
Michael Lynton
CHM | Chairman | 64 | 17-12-31 |
Gary Ginsberg
BRD | Director/Board Member | 61 | 20-04-29 |
Gary Sender
BRD | Director/Board Member | 62 | 19-06-30 |
Director/Board Member | 60 | 19-01-22 | |
Richard Friesner
FOU | Founder | 71 | 89-12-31 |
Ramy Farid
CEO | Chief Executive Officer | 59 | 01-12-31 |
Nancy Thornberry
BRD | Director/Board Member | 67 | 19-09-23 |
Director/Board Member | 68 | 20-04-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,164,193 | 0 | 0 | 85.31 % |
Stock B | 1 | 63,515,197 | 62,001,598 ( 97.62 %) | 0 |
Company contact information
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.91% | 1.53B | |
+17.72% | 3,216B | |
+14.91% | 88.91B | |
+14.45% | 82.48B | |
+38.93% | 53.11B | |
-16.74% | 51.66B | |
+34.48% | 45.09B | |
-31.36% | 42.47B | |
+82.25% | 42.1B | |
-0.58% | 27.17B |
- Stock Market
- Equities
- SDGR Stock
- Company Schrödinger, Inc.